SCHEMBL21821683

SCHEMBL21821683

O=C1CC(C2CC2)CC(=O)C1=CNCCN1CCN(CCO)CC1

nearest known ligand 0.36

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ PKM P14618 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SLC18A3 Q16572 1/20 0.31
▸ MAPT P10636 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21821919 0.91 ALDH1A1 (0.38) SMN1; SMN2LMNAALDH1A1
SCHEMBL22075549 0.91 SMN1; SMN2 (0.33) SMN1; SMN2LMNAALDH1A1
SCHEMBL21821843 0.91 SMN1; SMN2 (0.33) SMN1; SMN2LMNAALDH1A1
Hydrochloric Acid SCHEMBL21822027 0.90 GNAI3 (0.33) SMN1; SMN2LMNAALDH1A1
SCHEMBL21821771 0.85 SMN1; SMN2 (0.35) SMN1; SMN2LMNAALDH1A1MAPTNPSR1
SCHEMBL21822021 0.82 LMNA (0.36) SMN1; SMN2LMNAALDH1A1KMT2ACYP3A4
SCHEMBL21821574 0.80 KMT2A (0.34) SMN1; SMN2LMNAALDH1A1PKMKMT2A
SCHEMBL21821612 0.80 POLB (0.34) SMN1; SMN2LMNAALDH1A1PKMKMT2A
SCHEMBL21821744 0.80 LMNA (0.32) SMN1; SMN2LMNAALDH1A1KMT2AMAPT
SCHEMBL21821775 0.79 KDM4E (0.39) SMN1; SMN2LMNAALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632903-B1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2023-10-11 — — EP disclosed
EP-3632903-B1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN) 2023-10-11 — — EP disclosed
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 — — US disclosed
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 — — US disclosed
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-06-18 — — US disclosed
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-06-18 — — US disclosed
EP-3632903-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) 2020-04-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof ATG7, SQSTM1, BECN1 SMN1; SMN2 4684/4885LMNA 3953/4885ALDH1A1 4264/4885
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF ATG7, SQSTM1, BECN1 SMN1; SMN2 4684/4885LMNA 3953/4885ALDH1A1 4264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback